HR 7057
116th Congress
House
Health
Cardiovascular and respiratory health
Congressional oversight
Emergency medical services and trauma care
Health facilities and institutions
Health information and medical records
Health programs administration and funding
Health promotion and preventive care
Immunology and vaccination
Infectious and parasitic diseases
Medical research
Medical tests and diagnostic methods
Neurological disorders
Research administration and funding
U.C.S. ME/CFS Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 28, 2020
Referred to the House Committee on Energy and Commerce.
May 28, 2020
Introduced in House
Plain-English summary
Understanding COVID-19 Subsets and ME/CFS Act or the U.C.S. ME/CFS Act
This bill requires the National Institutes of Health to support research on myalgic encephalomyelitis/chronic fatigue syndrome among COVID-19 (i.e., coronavirus disease 2019) patients and survivors. This is a serious, chronic, and multisystem disease associated with survivors of viral infections. In addition, the Department of Health and Human Services may carry out a public awareness campaign about post-viral chronic neuroimmune diseases.
What's happening now
Referred to the House Committee on Energy and Commerce.
Committees of jurisdiction
1